# Corrigendum to “The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study”

Authors: Karina Karina; Louis Martin Christoffel; Rita Novariani; Imam Rosadi; Iis Rosliana; Siti Rosidah; Siti Sobariah; Novy Fatkhurohman; Nurlaela Puspitaningrum; Yuli Hertati; Irsyah Afini; Difky Ernanda; Tias Widyastuti; A. D. Sulaeha; Alfida Zakiyah; Noor Aini; Grady Krisandi; Hubert Andrew
Journal: Scientifica
 (2023)

---

## Body

## 2. Methods

This interventional preliminary study recruited 12 patients of both sexes between the age of 18–65 years as interim data of Phase II clinical trials. The study protocol was ethically approved by the Health Research Ethics Committee, University of Indonesia, and Cipto Mangunkusumo Hospital (HREC-FMUI/CMH) and is registered on ClinicalTrials.gov (NCT04715360).



---

*Source: 9846961-2023-02-03.xml*